Giant osteoclasts in patients under bisphosphonates

Area of Science:

• Bone biology and pathology
• Pharmacology of bone-targeting agents

Background:

• Bisphosphonates are standard treatments for high bone resorption conditions.
• They inhibit osteoclast activity through multiple mechanisms, including apoptosis induction.
• Previous studies noted decreased resorption but not necessarily decreased osteoclast numbers.

Observation:

• This paper details two patients with iliac crest bone biopsies showing unusual osteoclasts.
• These osteoclasts were large, multinucleated, and exhibited apoptosis.
• Crucially, these cells were not associated with active bone resorption.

Findings:

• Morphological analysis revealed giant, apoptotic osteoclasts in bisphosphonate-treated patients.
• Osteoclast size and morphology can be altered by bisphosphonate therapy.
• Atypical osteoclast presentation does not always correlate with resorption markers.

Implications:

• Accurate identification of these bisphosphonate-induced osteoclasts is critical for bone pathologists.
• Misinterpretation could lead to incorrect diagnoses, such as mistaking them for signs of hyperparathyroidism or malignancy.
• Understanding these morphological changes aids in accurate patient management and diagnosis.